BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21325666)

  • 21. Type 2 diabetes mellitus in youth: the complete picture to date.
    Gungor N; Hannon T; Libman I; Bacha F; Arslanian S
    Pediatr Clin North Am; 2005 Dec; 52(6):1579-609. PubMed ID: 16301084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein B, diabetes and medical consensus.
    Sniderman AD
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):2-3. PubMed ID: 20040795
    [No Abstract]   [Full Text] [Related]  

  • 23. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.
    El-Sakka AI; Sayed HM; Tayeb KA
    Urology; 2009 Sep; 74(3):552-9. PubMed ID: 19592073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of dyslipidemia in diabetes.
    Solano MP; Goldberg RB
    Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic dyslipidaemia.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Curr Opin Lipidol; 2006 Jun; 17(3):238-46. PubMed ID: 16680028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ; Lundman P; Tardif JC
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-enzymatic glycation in diabetic complications.
    Hussain F; Sheikh MA; Arif M; Arshad A; Jamil A
    Saudi Med J; 2008 Feb; 29(2):303-4. PubMed ID: 18246248
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell biology. Sorting out diabetes.
    Orme CM; Bogan JS
    Science; 2009 May; 324(5931):1155-6. PubMed ID: 19478173
    [No Abstract]   [Full Text] [Related]  

  • 30. The pancreatic β-cell in deadly encounter with apolipoprotein CIII.
    Juntti-Berggren L; Ali Y; Berggren PO
    Cell Cycle; 2015; 14(17):2715-6. PubMed ID: 26102210
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetic dyslipidemia and cardiovascular risk.
    Eckel RH
    Curr Diab Rep; 2008 Dec; 8(6):421-3. PubMed ID: 18990296
    [No Abstract]   [Full Text] [Related]  

  • 32. Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle.
    Valladolid-Acebes I; Berggren PO; Juntti-Berggren L
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and molecular biology: fatty acids and endoplasmic reticulum stress.
    Pétremand J; Widmann C
    Curr Opin Lipidol; 2011 Aug; 22(4):315-6. PubMed ID: 21743307
    [No Abstract]   [Full Text] [Related]  

  • 34. Apolipoprotein CIII is a new player in diabetes.
    Juntti-Berggren L; Berggren PO
    Curr Opin Lipidol; 2017 Feb; 28(1):27-31. PubMed ID: 27875339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The yin and yang of apolipoprotein CIII.
    Åvall K; Berggren PO; Juntti-Berggren L
    Diabetes Metab; 2018 Jun; 44(3):303-304. PubMed ID: 28495365
    [No Abstract]   [Full Text] [Related]  

  • 36. The Positive Association of Plasma Myristic Acid and Apolipoprotein CIII Concentrations.
    Fernandez ML
    J Nutr; 2020 Oct; 150(10):2613-2614. PubMed ID: 32805056
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2017.
    Ndisang JF; Vannacci A; Rastogi S
    J Diabetes Res; 2017; 2017():1478294. PubMed ID: 29279853
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diabetes mellitus with dyslipidemia].
    Sakurai K; Yokote K
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():131-6. PubMed ID: 23156380
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on: Gale EAM (2007) To boldly go -- or to go too boldly? The accelerator hypothesis revisited. Diabetologia 50:1571-1575 -- a reply to the editor.
    Wilkin TJ
    Diabetologia; 2007 Dec; 50(12):2604-6. PubMed ID: 17917712
    [No Abstract]   [Full Text] [Related]  

  • 40. A Unified Pathophysiological Construct of Diabetes and its Complications.
    Schwartz SS; Epstein S; Corkey BE; Grant SFA; Gavin Iii JR; Aguilar RB; Herman ME
    Trends Endocrinol Metab; 2017 Sep; 28(9):645-655. PubMed ID: 28629897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.